10.12.2012 Views

Conference Proceedings - School of Nursing & Midwifery - Trinity ...

Conference Proceedings - School of Nursing & Midwifery - Trinity ...

Conference Proceedings - School of Nursing & Midwifery - Trinity ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>School</strong> <strong>of</strong> <strong>Nursing</strong> & <strong>Midwifery</strong>, <strong>Trinity</strong> College Dublin: 8 th Annual Interdisciplinary Research <strong>Conference</strong><br />

Transforming Healthcare Through Research, Education & Technology: 7 th – 9 th November 2007<br />

<strong>Conference</strong> <strong>Proceedings</strong><br />

Back to contents page<br />

Evidenced-Based <strong>Nursing</strong> Practice Outcomes in Prevention <strong>of</strong><br />

Ventilator Associated Pneumonia<br />

Cindy L. Hawkins, RN BSN<br />

Clinical Nurse Specialist Graduate Student,<br />

University <strong>of</strong> Alabama, Huntsville<br />

Director <strong>of</strong> ICU, Marshall Medical Center North<br />

8000 US Hwy 69<br />

Guntersville, Alabama 35976<br />

Tel: 1 256 753 8364<br />

Fax: 1 256 753 8347<br />

Email: cindy.hawkins@mmcenters.com<br />

Background and context<br />

Ventilator-associated pneumonia (VAP) is a nosocomial infection in<br />

critically ill patients who receive mechanical ventilation. Nosocomial<br />

pneumonia is the second most common hospital-acquired infection.<br />

VAP occurs forty-eight hours or more after intubation – largely due<br />

to the tube bypassing the lungs normal protection mechanisms.<br />

With its high morbidity rate; increased length <strong>of</strong> stay; prolonged<br />

mechanical ventilation; and increase in costs, interventions are<br />

essential in impacting the care and outcomes <strong>of</strong> these patients. The<br />

incidence rate <strong>of</strong> VAP can be as high as 65% and a mortality rate up<br />

to 71%. The risk for death increases by 4.3 times compared to<br />

patients in the intensive care unit (ICU) without pneumonia. In the<br />

United States alone, VAP results in yearly expenditures <strong>of</strong><br />

approximately $1.5 million with an outstanding 1.75 million<br />

additional hospital days per year. The Center for Disease Control<br />

and Prevention states that the median rate per thousand ventilator<br />

days was 14.7 in trauma ICU’s and the patient had a greater risk by<br />

6 to 21 times in developing pneumonia than those patients not<br />

ventilated. Therefore prevention <strong>of</strong> VAP must be regarded as one <strong>of</strong><br />

the most important issues in critical care, and it has already become<br />

one <strong>of</strong> the core ICU performance measures proposed by the<br />

Intensive Care Advisory Panel <strong>of</strong> the Joint Commission on<br />

Accreditation <strong>of</strong> Healthcare Organizations.<br />

The significance <strong>of</strong> preventing VAP is to improve patient care,<br />

improve outcomes, and decrease incidence rates. The Institute for<br />

Healthcare Improvement (IHI) has started a campaign to nationally<br />

improve patient care and prevent avoidable deaths in ventilated<br />

patients as a part <strong>of</strong> the 100,000 Lives Campaign.<br />

Clinical practice guidelines which have been proven to decrease the<br />

incidence <strong>of</strong> VAP include basic hand washing, oral care, daily<br />

sedative interruption, assessment <strong>of</strong> readiness to extubate, semirecumbent<br />

positioning, deep vein thrombosis and peptic ulcer<br />

- 401 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!